The Federal Trade Commission has put three CBD companies on alert that "it is illegal to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence to support such claims."
The three companies, unnamed by the FTC, "sell oils, tinctures, capsules, 'gummies,' and creams" containing CBD. The federal commission urged the companies (and, by association, all CBD companies) to carefully review all health claims made with respect to their products and "to ensure they are supported by competent and reliable scientific evidence."
The move echoes a crackdown from the Food and Drug Administration, specifically its actions against Curaleaf's "unsubstantiated" CBD health claims.
From the FTC's Sept. 10 advisory:
Westword reports that Denver-based Cannabis Clinicians Colorado is seeking 16 retired athletes for a study on how CBD use addresses health issues like chronic pain.
Screening days are Sept. 27 and 28. The chosen participants will be involved in an eight-week research campaign looking at how certain CBD dosages and delivery systems impact physical and mental health. As the organization's website states: "Did you play football, hockey, MMA (mixed martial arts), volleyball, basketball, field hockey, soccer, etc? Do you have pain and/or mental issues resulting from your sport? Email Info@mjformds.com to see if you qualify for the study!"
The research mirrors similar projects taking place across athletic leagues and in the cannabis industry. Aurora Cannabis, a major licensed Canadian producer, teamed up earlier this year with UFC for a study on how CBD address pain incurred by fighters.
Former Israeli Prime Minister Ehud Barak described his country's growing cannabis industry at the CannX International Medical Conference this week. Pointedly, he remarked that current Prime Minister Benjamin Netanyahu has a "rich track record that he doesn't fulfill his promises" and specifically cited the slow development of cannabis regulations in Israel.
The country will hold a national election Sept. 17. News coverage hints at a tight race.
With that in mind, Barak wryly suggested that Netanyahu won't have any employment trouble if indeed he's ousted from office. "After we relieve Netanyahu in about a week from his post as Prime Minister, he has a lot of vacancies just waiting for him in the cannabis industry," Barak said at the conference. (Barak is on the board of InterCure. The company recently abandoned plans for an IPO.)
"Israel probably lost between one-third and one-quarter of the global cannabis industry's economic potential, following the regulatory delay in exporting cannabis," he said. "However, Israel has not yet lost in the global race and I definitely believe it will become a significant player in the global industry."
联邦贸易委员会已经提醒三家 CBD 公司“在没有足够可靠的科学证据支持这种说法的情况下，广告一种产品能够预防、治疗或治愈人类疾病是非法的。”
这三家公司未被联邦贸易委员会点名，“销售含有 CBD 的油、酊剂、胶囊、口香糖和奶油”。联邦委员会敦促这些公司（以及所有 CBD 公司联合）仔细审查对其产品提出的所有健康索赔，并“确保它们得到有能力和可靠科学证据的支持”。
此举呼应了美国食品药品监督管理局（Food and Drug Administration）（ FoodandDrugAdministration ）的打击行动，特别是针对 Curaleaf “未经证实”的 CBD 健康声明的行动。
WestWord 报道说，科罗拉多州丹佛市的 Cannabis Clinicians 正在寻找16名退休的运动员来研究 CBD 如何解决像慢性疼痛这样的健康问题。
筛选日期是9月27日和28日。入选的参与者将参与为期8周的研究活动，研究某些 CBD 剂量和给药系统对身体和精神健康的影响。正如该组织的网站所说：“你是踢足球、曲棍球、 MMA （混合武术）、排球、篮球、田曲棍球、足球等吗？你有运动引起的疼痛和/或精神问题吗？电子邮件 Info @ mjformds.com ，查看您是否符合申请资格！""
这项研究反映了在体育联盟和大麻行业进行的类似项目。加拿大主要特许生产商奥罗拉（Aurora） Cannabis 今年早些时候与 UFC 合作进行了一项研究，研究 CBD 如何应对战斗机造成的疼痛。
前以色列总理巴拉克（ EhudBarak ）在本周的坎nX 国际医疗会议上描述了他的国家不断增长的大麻产业。他指出，现任总理内塔尼亚胡有“丰富的记录表明他没有履行他的承诺”，并特别提到以色列大麻法规发展缓慢。
考虑到这一点，巴拉克委屈地暗示，如果内塔尼亚胡确实被免职，他将不会有任何就业问题。巴拉克在会议上说：“在我们解除内塔尼亚胡总理一周的职务后，他有很多空缺等待他进入大麻产业。”（巴拉克是 InterCure 的董事会成员。该公司最近放弃了 IPO 计划。）